# Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

> **NCT02762877** · — · TERMINATED · sponsor: **Genomic Health®, Inc.** · enrollment: 140 (actual)

## Conditions studied

- Non Small Cell Lung Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02762877
- **Lead sponsor:** Genomic Health®, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2018-07-01
- **Final completion:** 2019-06-19
- **Target enrollment:** 140 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762877, "Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT02762877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*